US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 27, 2018 (8 years ago)

Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.

What was recalled

Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC 0955-1020-01

Recalling firm
Sanofi-Aventis U.S. LLC
NDC code
0955-1020-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0804-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Docetaxel recalls

See all